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Neuropathology of Heavy Metal
Intoxication
by Martin R. Krigman*
The basis for utilizing altered morphology, i.e., pathology, in defining diseases ofthe nervous sytem is
presented. The importance of recognizing the dynamics of pathologic processes is emphasized, particu-
larly in understanding the pathogenesisofneural diseases. Demonstrative examplesofthe neuropathology
ofhuman heavy metal toxicity are presented. The limitations ofdescriptive pathology areconsidered, and
the potentials ofquantitative (morphometric) analysis for studying pathologic processes are introduced.
Introduction
Neurotoxicity may be an important feature of
heavy metal intoxication. However, for us to rec-
ognize the neurotoxic effects of an agent, there
must be a reproducible constellation of functional,
biochemical,-and structural alterations. Generally,
we first recognize the dysfunction of the nervous
system and then we search for the biochemical and
structural correlates ofthe neural disorder. This re-
port will be confined to a consideration of the mor-
phologic changes, or so-called pathology of heavy
metal neurotoxicity.
In defining a disease, we are looking for a repro-
ducible pattern and evolution ofthe pathology. The
analysis of the morphologic changes of a disease
state is based upon identifying the elements af-
fected, defining the changes the elements undergo,
and determining the extent of these changes. De-
pending upon the structural level of analysis, the
pathologic features may be identified at the level of
the organelle, cell,. and/or tissue. Finally, the se-
quence or pathogenesis ofthese alterations must be
determined.
In terms of the nervous system, the number of
cellular elements which must be identified and con-
sidered makes neuropathology appear unduely
complex. However, at the level of the cell,
neuropathology is not unique (I); neural elements
undergo necrosis, injury, and repair comparable to
cells in systemic tissues (2). Neuronal injury may be
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the result of a direct effect on the soma or secon-
dary to axon injury. Neurons can also be affected
by a reduced afferent input and undergo a form of
secondary injury, so-called transsynaptic degener-
ation. Myelin degeneration may result from pro-
cesses or agents directly affecting the myelin sheath
or its cell of origin (the Schwann cell or oligoden-
droglia in the peripheral and central nervous sys-
tems, respectively). Demyelination also follows
axon degeneration. The axon may be directly af-
fected by an agent or process or indirectly affected
by loss ofits somal origin. The astrocyte is a highly
sensitive cell which responds in a limited manner:
astrocytes increase in numbers (astrocytosis) and/or
also produce intracellular glial fibers (gliosis). The
astrocyte generally responds by proliferation and
formation ofglial fibers except in cases ofmetabolic
dysfunctions, when the cell responds by just nu-
clear enlargement and proliferation. Microglia are
the central nervous system macrophages, and these
elements respond by activation and phagocytosis.
Blood vessels may be directly affected by agents or
respond in a secondary manner to neural tissue in-
jury. Irrespective of the genesis of the vascular
changes, when capillaries or venules are affected,
the blood-barrier systems are perturbed. Metabolic
dysfunction and/or cerebral edema may result from
the blood-brain barrier dysfunction. The
neurocytopathologic consequences of cerebral
edema include astrocytic and microglial reactions
and in some instances demyelination. The topo-
graphic distribution ofthe lesions can be described
in terms of central or peripheral nervous system,
117gray or white matter, regions of the brain, or
specific nuclei. The analysis of the distribution of
the lesions is important in comparing cases for de-
termining the reproducible nature ofthe pathology.
In analyzing the observations, the dynamic na-
ture of biologic reactions must be considered. The
type ofcellular reaction, i.e., primary or secondary,
must be recognized. The dynamic nature of the
changes must also be taken into account, insofar as
the cell reactions may include a continuum of de-
generation and repair. Moreover, other failing or-
gans may produce secondary brain changes, i.e.,
metabolic encephalopathy. Age must also be con-
sidered; the developing nervous system responds
differently than the mature system, and the lesions
ofaging must be distinguished from the effects ofa
toxin. The recognition of these complex interac-
tions are important for understanding the
pathogenesis of any neural toxin including heavy
metals. Moreover, the nervous system is a multi-
system organ, and this mustbe considered in under-
standing the pathogenesis ofa disease. As we learn
more about the nervous system, an analysis of the
pathology in terms offunctional units may provide a
more rational basis for understanding the selective
features of a given neurotoxin.
Neuropathology of Human Heavy
Metal Toxicity
The cogent pathologic features of heavy metal
neurotoxicity in man are presented in Table 1.
These descriptions are briefnotations ofthe general
findings in man (3) and illustrate the diversity of
neuropathologic findings caused by the different
metals. Particular emphasis is also placed on the
nature and distribution ofthe lesions.
Lead affects both the central and peripheral ner-
vous systems of man (3-5). The peripheral
neuropathy has long been recognized and charac-
teristically effects the somatic motor nerves. The
neuropathy in man is characterized by a loss of
nerve fibers (axons and myelin sheaths), and to
some degree segmental demyelination. Gray and
white matter lesions are variable; proliferation of
capillary endothelial cells and edema are the most
consistent lesions reported. The vascular changes
may be accentuated in the cerebellum. Neuronal
necrosis is a variable finding and, when present,
usually involves the neocortex and may be the re-
sult ofthe vasculopathy and anoxia. Astrocytes and
microglia exhibit an activated state, and the most
marked reactions are centered about small blood
vessels, particularly in those cases with endothelial
celldamage. Cases ofencephalopathy with seizures
and coma have been reported in which there are no
discernible pathologic changes (5). Neurotoxicity is
not a feature of cadmium toxicity (6, 7). Anosmia
has been reported but these cases have been associ-
ated with very heavy dust environments (7). Ar-
senic compounds (3, 8, 9), irrespective oftheir mo-
lecular form, may produce in man an acute en-
cephalopathy, and chronic exposure may lead to a
neuropathy (3-9). The encephalopathy affects pre-
dominantly the white matter and is thought to be an
allergic response (8). The neuropathy involves both
sensory and motor fibers and is characterized by
both axon and myelin degeneration (9). Concomi-
tantwith the motorneuronfiberdegeneration is loss
ofanterior horn cells. Alkylmercury (3, 10) burdens
produce in man a degeneration in both the central
and peripheral nervous system. The neurotoxicity
reflects a cumulative intoxication in which a mini-
mal level is required prior to the onset ofdegenera-
tion. The central nervous system changes involve
the cerebellum, cerebral cortex, and basal ganglia.
In the cerebellum there is a marked loss ofinternal
granular layer neurons compared to the relative
preservation of the Purkinje cells. The cerebral
cortex exhibits not only a slight to moderate diffuse
Table 1. Neuropathologic features of human heavy metal toxlcity.a
Peripheral nervous systemb Central nervous systemb
Sensory Motor Gray matter White matter Regions affected Nuclei affected
Lead 0 + + + Cerebellum
Cadmium 0 0 0 0
Arsenic + + 0 +
Alkylmercury + 0 + 0 Cerebellum Granular
layer
Basal ganglia Putamen
frontal, parietal, Motorsensory
andoccipital lobes visual
Manganese 0 0 0 0 Basal ganglia Globus pallidus
cerebellum
a The features are a compendium of multiple reports and constitute the most consistent findings observed.
b 0, abnormalities absent; +, abnormalities present.
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the visual cortex, and a moderate neuronal loss in
the precentral motor and postcentral sensory cor-
tex. The basal ganglia exhibit a loss ofneurons par-
ticularly in the putamen. The peripheral neuropathy
is most prominent in the sensory system and is
characterized by axon and myelin degeneration.
The neurotoxicity ofinorganic mercury is compara-
ble to that of alkylmercury (3). Manganese toxicity
(3, 11, 12) in humans affects the basal ganglia and to
some degree the cerebellum. The basal ganglia
change is characterized by an appreciable loss of
neurons in the medial aspect ofthe globus pallidus.
This lesion of the basal ganglia is a consistent ob-
servation. Less frequent is a reginal or lobularlike
loss ofboth the Purkinje cells and internal granular
layer neurons of the cerebellum. Peripheral
neuropathy is not a feature of manganese intoxica-
tion.
Morphometric Approach
to Neuropathology
The above neuropathologic descriptions are from
overt cases of toxicity. The reports were based
upon obvious changes, i.e., discernible loss of
neurons, myelin, and/or axons and with an
astrocytic reaction. However, throughout the liter-
ature there are cases of heavy metal burdens with
clinical evidence of neurotoxicity but with no dis-
cernible pathologic changes. Such cases, ofcourse,
can be described in terms of biochemical lesions.
The structural correlates and basis for the disease
may not be apparent to a qualitative morphologic
approach. A quantitative or morphometric analysis
of these cases may be more revealing because the
pathologic changes may not be in terms of a struc-
tural alteration but in a change in the numbers or
proportions ofcritical elements. The morphometric
studies are based upon applying stereologic proce-
dures to tissue sections in a defined and coordinated
manner (13). The methods may be applied to light
and electron microscopic studies (13). Morphomet-
ric studies provide information which may then be
subjected to statistical analysis. The morphometric
studies can be applied to clinical material and have
been widely used in analyzing nerve biopsies (14).
Autopsy material can be studied at the cellular
level; however, the artifacts intrinsic to such ma-
terial limit quantitative studies at the ultrastructural
level.
Morphometric analyses have been applied to a
number of toxicologic problems. In our laboratory
we utilized this approach to distinguish between the
effects of lead intoxication and undernutrition on
the developing brain (15-18). In brief, lead intox-
ication was produced in newborn rats by the
Pentschew-Garro method (19). Suckling rats are
initially exposed to lead via the milk and later expo-
sure is to the feed shared with the mother. The lead
in the diet affects the mother's nutrition, and this
raises the question of which are effects of lead and
which effects are related to nutrition? Suckling rats
were undernourished by removing the nursing dam
from her litter for increasing periods of time each
day. The treated (lead and undernourished) pups
and age-matched naive control pups were sacrificed
at 30 days ofage, and morphometric analyses were
undertaken in a defined region of somatosensory
cortex or pyramidal tract in the medulla. The mor-
phometric analyses demonstrated that there are
distinct and significant differences between the ef-
fects of lead toxicity and of undernutrition on the
postnatal development of the rat nervous system.
Astrocytic proliferation is retarded in the under-
nourished rat compared to the lead-treated rat
Table 2. Quantitative analysis of somatosensory cortex of
30-day rats.
Control Lead Undernourished
Glia x 10-4 per mm3 8.21 9.43 6.10
Neurons x 10-4 per mm3 7.05 8.98 10.1
Neuropil, % of cortex 66 57 63
Synapses x 10-8 permm3 6.17 5.81 4.57
Synapses per neuron x 10-3 8.75 6.46 4.31
Table 3. Morphometric features of an average terminal bouton in
molecular layer of 30-day rats.
Control Lead Undernourished
Axial ratio 0.66 0.68 0.80
Volume, ,m3 0.17 0.18 0.29
Total surface, ,um2 4.9 5.0 7.6
Dense line surface, ,um2 0.93 1.0 1.0
Table 4. Morphometric analysis of myelin and axons of
30-day rats.a
Under-
Control Lead nourished
Myelinated fibers, % 43 41 34
Promyelinated, % of myelinated 0.3 0.3 4.5
axons
Mean number of myelin lamellae 8.9 7.8 6.3
per myelinated axon
Width of myelin lamella, nm 10.7 11.7 10.7
Mean diameter of myelinated 1.64 1.52 1.54
axons, ,im
Diameter of axon when initial 0.41 0.32 0.44
myelin lamella appears, ,um
a Values based upon the analysis ofthe pyramidal tract in the
medulla of three control, three lead, and three undernourished
rats.
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60-day rats.a
Dosage, mg/kg Pb-day
Control 25 200
Neuron x 10-5 per mm3 1.38 1.27 1.18
Glia x 10-5 per mm3 4.41 3.57 3.37
Boutons x 10-8 per mm3 4.52 3.90 2.94
Synapses per neuron x 10-3 3.32 3.07 2.52
a Rats were dosed by gastric gavage with 0, 25, or 200 mg
Pb/kg-day from day 2 through day 30 oflife and were maintained
on a "lead-free" diet for the next 30 days.
(Table 2). The form of the synaptic boutons is
different in the undernourished pups (Table 3);
while the boutons are larger in the undernourished
rat, the surface area of contact points, i.e., the
membrane densities, are the same in all three
groups. Myelination is retarded in the under-
nourished rat; properly sequenced hypomyelination
was observed in the lead-treated rat (Table 4).
The Pentschew-Garro lead model and the under-
nutrition model are extreme paradigms for lead
toxicity and malnutrition; yet it required a quantita-
tive study to elucidate the full range ofdifferences.
We have applied a morphometric analysis to a low
level oflead toxicity in which the changes are more
subtle (20, 21). Suckling rats were exposed to de-
fined lead burdens for the first 30 days of life. The
pups were kept on a normal, relatively lead-free diet
for the next 30 days and were sacrificed at 60 days
of age. A morphometric analysis of a predefined
region of caudate nucleus was undertaken at the
cellular and ultrastructural level. The results dem-
onstrated an effect on postnatal neuron develop-
ment and synaptogenesis (Table 5). The lead effects
also appear to be dose-dependent.
Neuropathologic studies of toxicants such as
heavy metals are dependent upon recognition of
cellular changes and altered ultrastructure. Tradi-
tionally, these studies have been based upon recog-
nizing qualitative differences; however, few studies
have attempted to define in a quantitative manner
these differences. Contemporary neuropathologic
studies, particularly those related to neurotoxicol-
ogy, will have to include objective quantitative
structural analyses which can be subjected to
statistical analysis. Such morphometric studies are
necessary not only for demonstrating and defining
the subtle undue burdens of toxicants but for dem-
onstrating the full range ofthe effects. Quantitative
base-line data are needed for determining the po-
tential for regeneration and distinguishing between
aging and toxin effects.
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